Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Biphasic Insulin Aspart Regimens vs Biphasic Human Insulin in Type 2 Diabetes
NCT01526980Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- May 2002
- Primary completion
- Nov 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started May 2002; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01526980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01526980.